Venue and Accommodations
Learning Objectives
Online Registration Form
Fax Registration Form
      Program Overview  

Emerging Strategies in the Personalized Treatment of Breast Cancer

Program Director
Mark Pegram, MD, Professor, Stanford Medical School, Director, Breast Cancer Oncology Program, Stanford Cancer Institute, Stanford, CA

August 23, 2014
Houston Marriott at the Texas Medical Center
6580 Fannin Street, Houston;  Website

Jointly sponsored by
The A. Webb Roberts Center for CME of Baylor Health Care System, CancerNet and American Health Resource, Inc.

For online registration and more information visit: www.cancernetus.com

Educational Grants
This activity is supported by education grants from:
Eisai, Inc
Novartis Pharmaceuticals Corporation

Statement of Need/Program Overview This symposium is intended to improve care of patients with breast cancer by accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty.

Target Audience
This symposium is directed primarily to hematologists/oncologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in breast cancer. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Outline treatment options for advanced/metastatic breast cancer
  • Evaluate optimal adjuvant hormonal therapy in breast cancer
  • Identify adjuvant and neoadjuvant treatment options for triple negative breast cancer
  • Identify emerging chemotherapeutic use of mTOR inhibitors and endocrine agents in treatment of breast cancer
  • Describe strategies to treat metastatic bone disease in women with breast cancer
  • Indicate the utility of molecular profiling in breast cancer patients
  • Identify the use of prognostication tools such as EndoPredict Score and Oncotype DX RS for breast cancer
  • Describe the current status of radiation therapy in optimizing local control in breast cancer
  • Identify the role of accelerated hypofractionated breast radiation therapy
  • Review supportive care and quality of life issues in the management of patients with breast cancer
  • Discuss practice guidelines and its impact on reimbursement issues in the treatment of breast cancer

Registration Fee
Registration fee partially covers continental breakfast, lunch and syllabus book

Registration Fee
8/16/14 to 8/23/14
Physicians $135.00
Registered Nurses $85.00
Nurse Practitioners/Physician Assistants $85.00
Pharmacists $85.00
Fellows $85.00
*Industry $350.00
*Person(s) employed by for-profit organizations such as pharmaceutical and biotech companies, and financial institutions

Payment may be made: MC   Visa  Discover  Amex  Check

Credit Card Number___________________________ Expiration Date_______________

Name and address________________________________________________________
As given on the monthly credit card statement
No refund. Substitution is allowed.

Register online at www.cancernetus.com

Please make checks payable to CancerNet, LLC. Mail checks to CancerNet, 860 Hebron Pkwy, Suite 1104, Lewisville, TX 75057

To reserve your place for the meeting, please complete the registration form and fax it 443-267-0016. For questions if any please call Brian Waggoner at 972-459-5222 or E-mail: brianw@cancernetus.com

Physician Continuing Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the co-providership of A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System and CancerNet. The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement
American Health Resource is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This activity provides 6.5 contact hours (0.65 CEUs) - Knowledge based credits ACPE Universal Activity Number: 0280-9999-14-066-L01-P.

Nursing Continuing Education
Accreditation Statement

American Health Resources, Inc. is approved by the California Board of Registered Nursing, Provider # CEP 14254 and approved this program for 6.5 contact hours. Please check with licensing board to verify credits can be claimed in your state.

Participant Requirement and Statement of Credit:

  • Participants must fully attend all sessions as well as pass in a completed signature verification form with NAPB e-profile number and birth date (MMDD) information (No partial credit will be given).
  • Participants can earn Continuing Pharmacy Education credits for this program by electronically logging onto the website https://ce.ahrevents.com/ and completing the session evaluation form for sessions attended within 60 days of session date. After completion of the activity evaluation, your continuing pharmacy education credit is automatically reported to CPE Monitor where a certificate of credit can be printed. Please allow up to 48 hours for credit to be available on the CPE Monitor.
  • Participant names will be checked against program attendance sheets for verification of attendance.


Home    |     Live Events    |     Webcasts    |     About CancerNet    |     Contact Us

Copyright © 2012 Cancernet. All rights reserved.